title: Protein kinase A and phosphodiesterase-4D3 binding to coding polymorphisms of cardiac muscle anchoring protein (mAKAP).
abstract: Protein kinase A (PKA) substrate phosphorylation is facilitated through its co-localization with its signaling partner by A-kinase anchoring proteins (AKAPs). mAKAP (muscle-selective AKAP) localizes PKA and its substrates such as phosphodiesterase-4D3 (PDE4D3), ryanodine receptor, and protein phosphatase 2A (PP2A) to the sarcoplasmic reticulum and perinuclear space. The genetic role of mAKAP, in modulating PKA/PDE4D3 molecular signaling during cardiac diseases, remains unclear. The purpose of this study was to examine the effects of naturally occurring mutations in human mAKAP on PKA and PDE4D3 signaling. We have recently identified potentially important human mAKAP coding non-synonymous polymorphisms located within or near key protein binding sites critical to β-adrenergic receptor signaling. Three mutations (P1400S, S2195F, and L717V) were cloned and transfected into a mammalian cell line for the purpose of comparing whether those substitutions disrupt mAKAP binding to PKA or PDE4D3. Immunoprecipitation study of mAKAP-P1400S, a mutation located in the mAKAP-PDE4D3 binding site, displayed a significant reduction in binding to PDE4D3, with no significant changes in PKA binding or PKA activity. Conversely, mAKAP-S2195F, a mutation located in mAKAP-PP2A binding site, showed significant increase in both binding propensity to PKA and PKA activity. Additionally, mAKAP-L717V, a mutation flanking the mAKAP-spectrin repeat domain, exhibited a significant increase in PKA binding compared to wild type, but there was no change in PKA activity. We also demonstrate specific binding of wild-type mAKAP to PDE4D3. Binding results were demonstrated using immunoprecipitation and confirmed with surface plasmon resonance (Biacore-2000); functional results were demonstrated using activity assays, Ca(2+) measurements, and Western blot. Comparative analysis of the binding responses of mutations to mAKAP could provide important information about how these mutations modulate signaling.
authors.affiliation: Department of Pharmacological and Pharmaceutical Sciences, University of Houston, Texas Medical Center, Houston, TX 77204, USA.
authors.forename: Abeer
authors.initials: A
authors.lastname: Rababa'h
authors.forename: John W
authors.initials: JW
authors.lastname: Craft
authors.forename: Cori S
authors.initials: CS
authors.lastname: Wijaya
authors.forename: Fatin
authors.initials: F
authors.lastname: Atrooz
authors.forename: Qiying
authors.initials: Q
authors.lastname: Fan
authors.forename: Sonal
authors.initials: S
authors.lastname: Singh
authors.forename: Ashley N
authors.initials: AN
authors.lastname: Guillory
authors.forename: Panagiotis
authors.initials: P
authors.lastname: Katsonis
authors.forename: Olivier
authors.initials: O
authors.lastname: Lichtarge
authors.forename: Bradley K
authors.initials: BK
authors.lastname: McConnell
mesh_terms: D054758:A Kinase Anchor Proteins / Q000737:chemistry / Q000235:genetics* / Q000378:metabolism*; D019943:Amino Acid Substitution / Q000502:physiology; D000818:Animals; D001665:Binding Sites / Q000235:genetics; D016466:CHO Cells; D006224:Cricetinae; D003412:Cricetulus; D017868:Cyclic AMP-Dependent Protein Kinases / Q000378:metabolism*; D054703:Cyclic Nucleotide Phosphodiesterases, Type 4 / Q000378:metabolism*; D057809:HEK293 Cells; D006801:Humans; D009206:Myocardium / Q000201:enzymology*; D010766:Phosphorylation / Q000235:genetics; D020641:Polymorphism, Single Nucleotide / Q000502:physiology; D011485:Protein Binding / Q000235:genetics; D054730:Protein Interaction Domains and Motifs / Q000235:genetics / Q000502:physiology
chemical_list: D054758:A Kinase Anchor Proteins; C093173:AKAP6 protein, human; D017868:Cyclic AMP-Dependent Protein Kinases; D054703:Cyclic Nucleotide Phosphodiesterases, Type 4
keywords: 3-isobutyl-1-methylxanthine; A-kinase anchoring protein; AKAP; CHO; CREB; Chinese hamster ovary; ET; G-protein coupled receptor kinase 2; GRK2; HEK; HF; IBMX; NCBI; NFATc; National Center for Biotechnology Information; PDE; PDE4D3; PKA; PP2A; PP2B; RU; RyR2; SPR; UCSC; University of California Santa Cruz; WT; beta-adrenergic receptor; cAMP-response element binding; evolutionary trace; heart failure; human embryonic kidney; hypertrophy; immunoprecipitation; mAKAP; muscle-selective A-kinase anchoring protein; nuclear factor of activated T cells; phosphodiesterase; phosphodiesterase-4D3; protein kinase A; protein phosphatase 2A; protein phosphatase 2B, calcineurin; response unit; ryanodine receptors; surface plasmon resonance; wild type; β-AR; β-adrenergic receptor